Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cross reactivity of spike glycoprotein induced antibody against Delta and Omicron variants before and after third SARS-CoV-2 vaccine dose in healthy and immunocompromised individuals.
Faustini S, Shields A, Banham G, Wall N, Al-Taei S, Tanner C, Ahmed Z, Efstathiou E, Townsend N, Goodall M, Plant T, Perez-Toledo M, Jasiulewicz A, Price R, McLaughlin J, Farnan J, Moore J, Robertson L, Nesbit A, Curry G, Black A, Cunningham A, Harper L, Moore T, Drayson M, Richter A. Faustini S, et al. Among authors: banham g. J Infect. 2022 Apr;84(4):579-613. doi: 10.1016/j.jinf.2022.01.002. Epub 2022 Jan 10. J Infect. 2022. PMID: 35016901 Free PMC article. No abstract available.
Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients.
Carr EJ, Wu M, Harvey R, Wall EC, Kelly G, Hussain S, Howell M, Kassiotis G, Swanton C, Gandhi S, Bauer DL; Haemodialysis COVID-19 consortium; Crick COVID Immunity Pipeline; Billany RE, Graham-Brown MP, Beckett J, Bull K, Shankar S, Henderson S, Motallebzadeh R, Salama AD, Harper L, Mark PB, McAdoo S, Willicombe M, Beale R. Carr EJ, et al. Lancet. 2021 Sep 18;398(10305):1038-1041. doi: 10.1016/S0140-6736(21)01854-7. Epub 2021 Aug 13. Lancet. 2021. PMID: 34391504 Free PMC article. No abstract available.
Belimumab in kidney transplantation: an experimental medicine, randomised, placebo-controlled phase 2 trial.
Banham GD, Flint SM, Torpey N, Lyons PA, Shanahan DN, Gibson A, Watson CJE, O'Sullivan AM, Chadwick JA, Foster KE, Jones RB, Devey LR, Richards A, Erwig LP, Savage CO, Smith KGC, Henderson RB, Clatworthy MR. Banham GD, et al. Lancet. 2018 Jun 30;391(10140):2619-2630. doi: 10.1016/S0140-6736(18)30984-X. Epub 2018 Jun 14. Lancet. 2018. PMID: 29910042 Clinical Trial.
Belimumab in kidney transplantation - Authors' reply.
Banham GD, Flint SM, Shanahan DN, Henderson RB, Clatworthy MR. Banham GD, et al. Lancet. 2019 Mar 2;393(10174):875-876. doi: 10.1016/S0140-6736(18)33066-6. Lancet. 2019. PMID: 30837145 No abstract available.
[No title available]
[No authors listed] [No authors listed] PMID: 31568399
14 results